GC62296
Ladarixin sodium
Also known as sodium methylsulfonyl-[(2R)-2-[4-(trifluoromethylsulfonyloxy)phenyl]propanoyl]azanide
Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist
ChemicalCAS865625-56-5MW397.32FormulaC11H11F3NNaO6S2
- CAS number
- 865625-56-5
- Molecular weight
- 397.32
- Formula
- C11H11F3NNaO6S2
- Solubility
- DMSO ： 100 mg/mL (251·69 mM; Need ultrasonic)
- InChIKey
- QICAUCDBOAKDNS-OGFXRTJISA-M
- Catalogue number
- GC62296
- Brand
- GLPBIO
Computed properties PubChem CID 23709380 · TPSA 112 Ų · H-bond donors 0 · H-bond acceptors 10
- TPSA
- 112 Ų
- H-bond donors
- 0
- H-bond acceptors
- 10
- Rotatable bonds
- 5
- Heavy atoms
- 24
SMILES C[C@H](C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)[N-]S(=O)(=O)C.[Na+]
Computed descriptors from PubChem (CID 23709380), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il